EP1383530A4 - Laminin 5, 13 and 14 and uses thereof - Google Patents

Laminin 5, 13 and 14 and uses thereof

Info

Publication number
EP1383530A4
EP1383530A4 EP98953599A EP98953599A EP1383530A4 EP 1383530 A4 EP1383530 A4 EP 1383530A4 EP 98953599 A EP98953599 A EP 98953599A EP 98953599 A EP98953599 A EP 98953599A EP 1383530 A4 EP1383530 A4 EP 1383530A4
Authority
EP
European Patent Office
Prior art keywords
laminin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98953599A
Other languages
German (de)
French (fr)
Other versions
EP1383530A2 (en
Inventor
William Joseph Brunken
Richard Thomas Libby
Dale Donald Hunter
Robert Eugene Burgeson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Tufts University
Original Assignee
General Hospital Corp
Tufts University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Tufts University filed Critical General Hospital Corp
Publication of EP1383530A2 publication Critical patent/EP1383530A2/en
Publication of EP1383530A4 publication Critical patent/EP1383530A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP98953599A 1998-10-13 1998-10-15 Laminin 5, 13 and 14 and uses thereof Withdrawn EP1383530A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10404498P 1998-10-13 1998-10-13
US104044P 1998-10-13
PCT/US1998/021866 WO2000021978A2 (en) 1998-10-13 1998-10-15 Laminin 5, 13 and 14 and uses thereof

Publications (2)

Publication Number Publication Date
EP1383530A2 EP1383530A2 (en) 2004-01-28
EP1383530A4 true EP1383530A4 (en) 2004-04-28

Family

ID=22298382

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98953599A Withdrawn EP1383530A4 (en) 1998-10-13 1998-10-15 Laminin 5, 13 and 14 and uses thereof

Country Status (4)

Country Link
EP (1) EP1383530A4 (en)
JP (1) JP2004500012A (en)
AU (1) AU1093199A (en)
WO (1) WO2000021978A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019078781A1 (en) * 2017-10-17 2019-04-25 National University Of Singapore Systems and methods for producing photoreceptor progenitors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012961A2 (en) * 1995-10-06 1997-04-10 Desmos, Inc. Growth of adult pancreatic islet cells with laminin 5
WO1997036621A1 (en) * 1996-03-29 1997-10-09 Desmos, Inc. Cellular attachment to laminin 5-coated trans-epithelial appliances
WO1997048415A1 (en) * 1996-06-05 1997-12-24 The General Hospital Corporation Laminin-5 and the formation of basement membrane structure

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012961A2 (en) * 1995-10-06 1997-04-10 Desmos, Inc. Growth of adult pancreatic islet cells with laminin 5
WO1997036621A1 (en) * 1996-03-29 1997-10-09 Desmos, Inc. Cellular attachment to laminin 5-coated trans-epithelial appliances
WO1997048415A1 (en) * 1996-06-05 1997-12-24 The General Hospital Corporation Laminin-5 and the formation of basement membrane structure

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
FUKUSHIMA YUJI ET AL: "Integrin alpha3beta1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells", INTERNATIONAL JOURNAL OF CANCER, vol. 76, no. 1, 30 March 1998 (1998-03-30), pages 63 - 72, XP001179723, ISSN: 0020-7136 *
LIBBY RICHARD T ET AL: "Laminin expression in adult and developing retinae: Evidence of two novel CNS laminins", JOURNAL OF NEUROSCIENCE, vol. 20, no. 17, 1 September 2000 (2000-09-01), pages 6517 - 6528, XP002271242, ISSN: 0270-6474 *
NAGY THOMAS ET AL: "Inhibition of retinal regeneration in larval Rana by an antibody directed against a laminin-heparan sulfate proteoglycan", DEVELOPMENTAL BRAIN RESEARCH, vol. 81, no. 1, 1994, pages 131 - 134, XP009026571, ISSN: 0165-3806 *
QIN PING ET AL: "Localization of basement membrane-associated protein isoforms during development of the ocular surface of mouse eye", DEVELOPMENTAL DYNAMICS, vol. 209, no. 4, 1997, pages 367 - 376, XP009026610, ISSN: 1058-8388 *
SILER ULRICH ET AL: "Characterization and functional analysis of laminin isoforms in human bone marrow", BLOOD, vol. 96, no. 13, 15 December 2000 (2000-12-15), pages 4194 - 4203, XP002271243, ISSN: 0006-4971 *
YANG C-H ET AL: "INHIBITION OF CELL-INDUCED VITREOUS CONTRACTION BY SYNTHETIC PEPTIDE DERIVED FROM THE COLLAGEN RECEPTOR BINDING SEQUENCE", JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, MARY ANN LIEBERT, INC., NEW YORK, NY, US, vol. 12, no. 3, 1996, pages 353 - 361, XP001053796, ISSN: 1080-7683 *

Also Published As

Publication number Publication date
AU1093199A (en) 2000-05-01
EP1383530A2 (en) 2004-01-28
WO2000021978A2 (en) 2000-04-20
JP2004500012A (en) 2004-01-08
WO2000021978A3 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
DE69941083D1 (en) 12,13-cyclopropan-epothilonderivate
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
HUP9904368A3 (en) Colostrinin,and uses thereof
SI1019358T2 (en) 3,3-diarylpropylamines , their use and preparation
BG105437A (en) Rheoogy modified compositions and processes thereof
IL143095A0 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
GB9806806D0 (en) Peptides and uses thereof
GB9706597D0 (en) Compositions,processes and uses
GB9608488D0 (en) Compositions, processes and uses
GB0026240D0 (en) Polymers and their uses
AU2001262963A1 (en) Laminin 15 and uses thereof
GB9608489D0 (en) Compositions, processes and uses
GB9810372D0 (en) Polymers and their uses
HUP0000498A3 (en) Novel calpaines, production and use thereof
GB9608491D0 (en) Compositions, processes and uses
GB9706136D0 (en) Compositions,processes and uses
IL145711A0 (en) Thrombospondin-2 and uses thereof
GB9608493D0 (en) Compositions, processes and uses
GB9705849D0 (en) Compositions, processes and uses
EP0998578A4 (en) Sel-10 AND USES THEREOF
EP1383530A4 (en) Laminin 5, 13 and 14 and uses thereof
GB9706322D0 (en) Compositions, processes and uses
GB2392159B (en) Endo-ß-1, 4, xylanase and uses thereof
GB9706291D0 (en) Compositions, processes and uses
EP1066051A4 (en) Sciellin and uses thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010511

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): DE FR GB IT

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/78 B

Ipc: 7A 61K 38/39 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040311

17Q First examination report despatched

Effective date: 20040706

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050118